Impact Factor 2018 : 1.587 (@Clarivate Analytics)
  • Users Online: 1069
  • Print this page
  • Email this page


 
 
Table of Contents
BASIC RESEARCH
Year : 2019  |  Volume : 9  |  Issue : 1  |  Page : 24-28

Anticancer activity of Salvia officinalis essential oil and its principal constituents against hormone-dependent tumour cells


1 Fondazione Mediterranea “G.B. Morgagni”, Catania 95125, Italy
2 Fondazione Mediterranea “G.B. Morgagni”, Catania 95125; Department of Medical and Surgical Sciences and advanced technologies, University of Catania, Catania 95123, Italy
3 Institute of Biomolecular Chemistry, Italian National Research Council ICB-CNR, Catania 95126, Italy

Date of Submission17-Nov-2018
Date of Decision11-Dec-2018
Date of Acceptance08-Jan-2019
Date of Web Publication21-Jan-2019

Correspondence Address:
G Privitera
Fondazione Mediterranea “G.B. Morgagni”, Via del Bosco, 105 - 95125 Catania
Italy
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2221-1691.250266

Get Permissions

  Abstract 

Objective: To investigate the in vitro antiproliferative action of essential oil from Salvia officinalis L. (S. officinalis) grown in Sicily (Italy), and its main components on hormone-dependent cancer cell lines. Methods: S. officinalis essential oil was prepared by hydrodistillation. The actions of the S. officinalis essential oil and its three principal components ( α -thujone, 1,8-cineole and camphor) were evaluated in LNCaP cells (prostate carcinoma), MCF7 cells (breast carcinoma) and HeLa cells (cervical carcinoma) at various dosages and diverse time points. Cell viability and proliferation were estimated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Results: S. officinalis essential oil at doses of 100 μg/mL and 200 μg/mL induced a significant reduction of cell viability in MCF7, LNCaP and HeLa cell lines after a 48-hour incubation. The same cell lines also showed decreased cell viability when they were treated with a mixture of three major components of the essential oil, at doses of 100 μg/mL and 200 μg/mL, after a 48-hour incubation. Conclusions: These preliminary results could shed light on the formulation of new therapeutic agents with antiproliferative activity. Thus supplementary investigations are fundamental to examine the molecular mechanisms of the anticancer effects of this species of Salvia in cancer cells and to achieve confirmation of its in vivo anticancer activity.

Keywords: Antiproliferative activity, Hormone-dependent cancers, Essential oil, Salvia officinalis


How to cite this article:
Privitera G, Luca T, Castorina S, Passanisi R, Ruberto G, Napoli E. Anticancer activity of Salvia officinalis essential oil and its principal constituents against hormone-dependent tumour cells. Asian Pac J Trop Biomed 2019;9:24-8

How to cite this URL:
Privitera G, Luca T, Castorina S, Passanisi R, Ruberto G, Napoli E. Anticancer activity of Salvia officinalis essential oil and its principal constituents against hormone-dependent tumour cells. Asian Pac J Trop Biomed [serial online] 2019 [cited 2019 Oct 20];9:24-8. Available from: http://www.apjtb.org/text.asp?2019/9/1/24/250266




  1. Introduction  Top


Cancer is one of the most malignant illness in the present decennium, and every year a lot of people die because of diverse cancers. Hormone-dependent tumors of the breast, uterine cervix and prostate are common in the Western world[1]. Current treatments include surgery, anti-hormone therapy, radiotherapy and chemotherapy; however, drug resistance, adverse effects and costs are forcing scientists to examine other sources to discover novel anticancer molecules.

Nature contains more than 1 000 species of plants with significant anticancer properties. The investigation of natural anticancer substances from plants and herbs initiated in 1960s, when vincristine, vinblastine, camptothecin and taxol were discovered[2]. These compounds are currently used in cancer therapies; for example, taxol is an Food and Drug Administration-approved cancer agent that has been used as a second-line therapy of refractory ovarian and breast cancers, refractory or anthracycline-resistant breast cancer, Kaposi’s sarcoma and non-small cell lung cancer[3]. The synthetic transformation of podophyllotoxin led to the formulation of etoposide, which is used to treat small cell tumors of the lungs and testes[4].

It used to be routine practice to examine medicinal plants to find the single active compound responsible for the curative effect[5], neglecting that the biological action may be the product of the association of activities of various substances. This was mainly due to the deficiency of high-quality studies on phytocomplexes, which turned into a general absence of recognition of natural medicine by the scientific society despite the promising results of these alternative traditional approaches.

Among the well-known phytocomplexes, essential oils (EOs) from aromatic plants have shown anticancer properties. EOs are plant volatile oils that have been extensively used in conventional medicine, and those from aromatic plants (and their constituents) have shown anticancer properties. The literature contains over 100 investigations of EOs from different plants used for in vitro and in vivo experiments of different kinds of cancer (i.e. mouth, breast, lung, prostate, liver, colon, brain and leukaemia)[6],[7],[8],[9],[10],[11],[12].

Salvia officinalis L. (S. officinalis) is an odorous perpetual plant that is endemic to southern Europe and Asia and is widely used for both dietary and medicinal compositions. Salvia is the largest genus of the Lamiaceae family, with around 900 species described worldwide[13]. It has different biological activities that are manifested by its different components[14],[15],[16], and this ‘panacea’ reputation is often just linked to its EO[17], even if its chemical composition is different due to genetic aspects and environmental factors[18].

Considering the interest in the possible anticancer properties of EOs from plants and herbs, the main goal of this investigation was to evaluate the actions of S. officinalis EO and its main components (α -thujone, 1,8-cineole and camphor) on three human hormone-dependent cancer cells: LNCaP (prostate carcinoma), MCF7 (breast carcinoma) and HeLa (cervical carcinoma). In light of the results and data reported in the scientific literature, these findings are very interesting and encourage further investigations on the mechanism of action of S. officinalis EO.


  2. Materials and methods Top


2.1. Chemicals

α -Thujone, 1,8-cineole, camphor, and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich (Italy).

2.2. Plant materials

Specimens of S. officinalis at bloom stage were collected in Avola, Siracusa province, Sicily, Italy, and the plants were dried naturally at the collection point (GPS: N 36°56’20”, E 14°58’51”). The plant samples were collected in the herbarium of the Agronomic Institute, University of Catania, after botanical characterization.

2.3. EO isolation and analysis

The EO of S. officinalis was prepared from the dried aerial part of this plant (100 g) by 3 hours of hydrodistillation as previously reported[19], and 2.15 mL of essential oil was recovered. Analytic method used and EO composition were already published in our previous work[16].

2.4. Cell cultures

Human hormone-dependent tumour cell lines, LNCaP (prostate cancer), MCF7 (breast cancer) and HeLa (cervical cancer), were kindly donated by the Department of Biomedical and Biotechnological Sciences, University of Catania, Italy. All cell culture media and supplements were purchased from Life Technologies (Carlsbad, CA 92008, USA) unless stated differently.

HeLa cells were grown in Dulbecco’s Modified Eagle’s Medium supplemented with 1% pyruvate, MCF7 cells were grown in Dulbecco’s Modified Eagle’s Medium with Glutamax-1 and LNCaP cells were grown in Roswell Park Memorial Institute media. Ten percent foetal bovine serum, 100 IU/mL penicillin and 100 μg/mL streptomycin were added in all media. Cells were cultured at 37 s°C and 5% CO2 in a humid environment. After 4-5 d, cells were washed with a buffer solution and trypsinized for 3-5 min.

2.5. Treatment of tumor cell lines with S. officinalis EO and a mixture of its main components

LNCaP (1.8 × 103 cells/well), MCF7 (2 × 103 cells/well) and HeLa cells (1 ×103 cells/well) cells were seeded in sterile 96-well plates and incubated overnight. After 24 h, the medium was replaced with the medium containing only 1% foetal bovine serum, and incubation continued at 37 °C in a humidified chamber. After serum starvation, cells were treated with increasing doses (50, 100 and 200 μg/mL) of S. officinalis EO or with three main components of S. officinalis EO (α -thujone, 1,8-cineole and camphor) and incubated for 24, 48 or 72 h. All cells treated with EO or a mixture of three main compounds were compared to the corresponding controls (cells treated with medium and DMSO only). Six wells were assigned to each treatment. Cell morphology was examined using a phase contrast microscope (Axiovert 40 CFL, Carl Zeiss Light Microscopy).

2.6. Determination of cell viability

The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was employed to quantify cell viability as previously described[16],[17],[18],[19],[20]. The results were also expressed in terms of viability using: % of cell viability = [OD (550–690 nm) test product/OD (550–690 nm) negative control] ×100. A reduction of cell viability by more than 30% was considered a cytotoxic effect[21].

2.7. Statistical analysis

All analyses were repeated 10 times, and six wells were assigned to each treatment. Data were presented as mean ± standard deviation (SD) and were evaluated with one-way ANOVA test, with P < 0.05 considered statistically significant.


  3. Results Top


Cell growth was determined using the MTT assay. No activity was observed in all cell lines when they were treated with S. officinalis EO and a mixture of its three major components at a dose of 50 μg/ mL for 24, 48 and 72 h (data not shown). Moreover, the treatment with 100 μg/mL and 200 μg/mL dose of S. officinalis EO caused a reduction in cell viability in all cell lines after only 48 hours of treatment. HeLa [Figure 1], MCF7 [Figure 2] and LNCaP cells [Figure 3] also showed decreased cell viability when they were treated with the EO main components at the doses of 100 μg/mL and 200 μg/mL each after only 48 hours of incubation. Moreover, a dose of 100 μg/mL produced a cytostatic effect in all cell lines after 48 h, and a dose of 200 μg/mL of S. officinalis EO appeared to be cytostatic in LNCaP cells and cytotoxic in MCF7 and HeLa cells. At the same treatment time, a dose of 100 μg/mL of treatment with the combination of three main components had a cytotoxic effect in MCF7 and HeLa cells and a cytostatic effect in LNCaP cells. A 200 μg/mL dose of treatment with the combination of three main components was cytotoxic in all tumour cell lines. In addition, the inhibition of cell viability was coupled with morphological changes in all treated cells, which were examined using an inverted light microscope. Cells treated with only DMSO remained normal in size and shape (data not shown).
Figure 1: Effect of S. officinalis EO and a mixture of its three main components on HeLa cell proliferation measured by MTT test after 48 hours of incubation.
(*) denotes significant differences (P<0.05) between cells treated with a dose of 100 μg/mL and untreated cells (DMSO 0.1% only). (#) denotes significant differences (P<0.05) between cells treated with a dose of 200 μg/mL and untreated cells (DMSO 0.2% only).


Click here to view
Figure 2: Effect of S. officinalis EO and a mixture of its three main components on MCF7 cell proliferation measured by MTT test after 48 hours of incubation.
(*) denotes significant differences (P<0.05) between cells treated with a dose of 100 μg/mL and untreated cells (DMSO 0.1% only). (#) denotes significant differences (P<0.05) between cells treated with a dose of 200 μg/mL and untreated cells (DMSO 0.2% only).


Click here to view
Figure 3: Effect of S. officinalis EO and a mixture of its three main components on LNCaP cell proliferation measured by MTT test after 48 hours of incubation.
(*) denotes significant differences (P<0.05) between cells treated with a dose of 100 μg/mL and untreated cells (DMSO 0.1% only). (#) denotes significant differences (P<0.05) between cells treated with a dose of 200 μg/mL and untreated cells (DMSO 0.2% only).


Click here to view



  4. Discussion Top


Breast cancer and cervical cancer are the most prevalent malignancies in women[22], and prostate carcinoma is the second most common cancer in men[23]. Conventional cancer treatments consist of anti-hormone therapy in the early stages of the disease, surgery, radiotherapy and chemotherapy; however, they often affect the patient’s quality of life due to their serious side effects. Therefore alternative and less toxic therapies are urgently needed.

EOs represent an attractive source of new anticancer molecules, and the recent literature demonstrates the growing interest in this field. EOs are concentrated hydrophobic liquids that are produced by aromatic plants. Their constituents are mainly mono- and diterpenes that belong to several chemical classes (i.e. hydrocarbons, phenols, alcohols, ethers and esters) and have been classified on the basis of their chemical profiles. EOs are considered more effective than their components due to their more selective and synergistic action[24].

Salvia species have been widely studied for their chemical composition and pharmacological profile. Some diterpenoid quinones isolated from the roots of S. officinalis showed cytotoxic and DNA-damaging action in human colon carcinoma (Caco-2) cells and human hepatoma (HepG2) cells[8]. Until today the anticancer properties of the Sicilian S. officinalis EO and its components had not been studied in human hormone-dependent tumour cell lines. Therefore this investigation aimed to test the effects of the whole oil and a mixture of the three main components ( α -thujone, 1,8- cineole and camphor) on breast, uterine and prostate cancer cells. The composition of S. officinalis EO was established using gas chromatography and mass spectrometry as reported in our previously published work[16].

Researchers demonstrated that α -thujone had a relevant antiproliferative activity against melanoma[25] and that low concentrations could improve CD3AK cell proliferation and function[26]. Other studies showed that α -thujone improved the cytotoxicity of colon cancer cells and inhibited lung metastasis of B16F-10 cells by inhibiting tumor cell proliferation, adhesion and invasion[27]. 1,8-Cineole showed antiproliferative effects against Molt 4B (T lymphoblast; acute lymphoblastic leukaemia) and HL-60 cells (human promyelocytic leukaemia cells)[7] and increased the penetration of the anticancer drug, 5-fluorouracil, through human skin[20]. The activation of the PI3K/AKT and MAPK/ ERK pathways and antioxidant activity may be involved in this action[12]. Camphor, 1,8-cineole and α -thujone showed cytotoxic activity[28]. EOs and their components act by various pathways and mechanisms, including apoptosis, cell cycle arrest, antimetastatic and antiangiogenic activities, DNA repair modulation, increased levels of reactive oxygen species and reactive nitrogen species[29]. Oxidative stress has been considered to be linked to the etiology of many diseases, including diabetes, atherosclerosis, chronic inflammation, viral infection, and neurodegenerative diseases[30],[31].

The results of our research demonstrate, for the first time, that S. officinalis EO exhibits antiproliferative activity against hormone- dependent cancer cells after only 48 hours of treatment. A treatment dose of 50 μg/mL produced no significant antiproliferative effect, while an EO dose of 100 μg/mL produced a cytostatic effect in all cell lines. A treatment dose of 200 μg/mL appeared to be cytostatic in LNCaP cells and toxic in MCF7 and HeLa cells. Interestingly, the combination of the three major components of the EO produced a cytotoxic effect in MCF7 and HeLa cells and a cytostatic effect in LNCaP cells at a dose of 100 μg/mL. But the combination of three substances was cytotoxic in all tumor cell lines when used at a dose of 200 μg/mL.

The antiproliferative effect of the EO and the mixture of its main compounds was probably related to its ability to penetrate through the cell wall and cytoplasmic membrane. Morphological observations of the cells using an inverted microscope showed modification of the cell membrane after 48 hours of treatment.

Many reports suggest that the major components of an oil reflect the biological activities of the EOs from which they were isolated[32]. In this study, although the whole oil showed antiproliferative effect, the cytotoxic activity of the three main components seemed to suggest they had specific toxic activity that was independent of any modulation by minor components of the oil or any synergic effect from the rest of the oil. This possibility has previously been discussed in the literature, where it was pointed out that diverse substances of EOs can affect cell growth in a different manner[6].

In light of these results and the data reported in the literature, these findings are interesting and should encourage further investigations on the mechanism of action of alternative low-toxicity molecules from Sicilian S. officinalis EO. The cytostatic and cytotoxic effects of the mixture (of the three main components) on breast, prostate and cervical cancer cells are clear and support the hypothesis that this could be used alone or in addition to conventional therapy for certain types of cancer[33].

In conclusion, EOs from aromatic plants showed anticancer properties against blood, mouth, breast, lung, prostate, liver, colon and brain cancer[9],[11],[34],[35],[36],[37],[38], and information about the antitumoral effect of S. officinalis EO on tumor cells is poor, if not absent, for hormone-dependent cancers. Therefore these results could shed light on the development of new therapeutic agents. An additional studies are necessary to investigate the molecular mechanisms of the anticancer properties of this species of Salvia in tumor cells and to obtain evidence of its in vivo antitumor effects.

Conflict of interest statement

We have no conflict of interest.



 
  References Top

1.
Sierra MS, Soerjomataram I, Antoni S, Laversanne M, Piñeros M, de Vries E, et al. Cancer patterns and trends in Central and South America. Cancer Epidemiol 2016; 44 (Suppl 1): S23-S42. Doi: 10.1016/ j.canep.2016.07.013.  Back to cited text no. 1
    
2.
Tamrat T, Yesudass DR. A review on anticancer activity of some plant-derived compounds and their mode of action. Nat Prod Chem Res 2018; 6: 4. Doi:10.4172/2329-6836.1000330.  Back to cited text no. 2
    
3.
Ojima I, Lichtenthal B, Lee S, Wang C, Wang X. Taxane anticancer agents: A patent perspective. Expert Opin Ther Pat 2016; 26(1): 1-20. Doi: 10.1517/13543776.2016.1111872.  Back to cited text no. 3
    
4.
Mukherjee A, Basu S, Sarkar N, Ghosh AC. Advances in cancer therapy with plant based natural products. Curr Med Chem 2001; 8(12): 1467-1486.  Back to cited text no. 4
    
5.
Gutiérrez-Rebolledo GA, Drier-Jonas S, Jiménez-Arellanes MA. Natural compounds and extracts from Mexican medicinal plants with anti-leishmaniasis activity: An update. Asian Pac J Trop Med 2017; 10(12): 1105-1110. Doi: 10.1016/j.apjtm.2017.10.016.  Back to cited text no. 5
    
6.
Aziz ZAA, Ahmad A, Setapar SHM, Karakucuk A, Azim MM, Lokhat D, et al. Essential oils: Extraction techniques, pharmaceutical and therapeutic potential - A review. Curr Drug Metab 2018; 19(13): 1100-1110. Doi: 10.2 174/1389200219666180723144850.  Back to cited text no. 6
    
7.
Blowman K, Magalhães M, Lemos MFL, Cabral C, Pires IM. Anticancer properties of essential oils and other natural products. Evid Based Complement Alternat Med 2018; 2018: 3149362. Doi: 10.1155/2018/3149362.  Back to cited text no. 7
    
8.
Pavithra PS, Mehta A, Verma RS. Induction of apoptosis by essential oil from P. missionis in skin epidermoid cancer cells. Phytomedicine 2018; 50: 184-195. Doi: 10.1016/j.phymed.2017.11.004.  Back to cited text no. 8
    
9.
Lima EJSP, Alves RG, D Elia GMA, Anunciação TAD, Silva VR, Santos LS, et al. Antitumor effect of the essential oil from the leaves of Croton matourensis Aubl. (Euphorbiaceae). Molecules 2018; 23(11): 2974. Doi: 10.3390/molecules23112974.  Back to cited text no. 9
    
10.
Zhong Z, Yu H, Wang S, Wang Y, Cui L. Anti-cancer effects of Rhizoma Curcumae against doxorubicin-resistant breast cancer cells. Chin Med 2018; 13: 44. Doi: 10.1186/s13020-018-0203-z.  Back to cited text no. 10
    
11.
Al-Otaibi WA, Alkhatib MH, Wali AN. Cytotoxicity and apoptosis enhancement in breast and cervical cancer cells upon coadministration of mitomycin C and essential oils in nanoemulsion formulations. Biomed Pharmacother 2018; 106: 946-955. Doi: 10.1016/j.biopha.2018.07.041.  Back to cited text no. 11
    
12.
Russo A, Cardile V, Graziano ACE, Avola R, Bruno M, Rigano D. Involvement of Bax and Bcl-2 in induction of apoptosis by essential oils of three Lebanese Salvia species in human prostate cancer cells. Int J Mol Sci 2018; 19(1): 292. Doi: 10.3390/ijms19010292.  Back to cited text no. 12
    
13.
Khoury M, Stien D, Eparvier V, Ouaini N, El Beyrouthy M. Report on the medicinal use of eleven Lamiaceae species in Lebanon and rationalization of their antimicrobial potential by examination of the chemical composition and antimicrobial activity of their essential oils. Evid Based Complement Alternat Med 2016; 2016: 2547169. Doi:10.1155/2016/2547169.  Back to cited text no. 13
    
14.
Kamatou, GP, Makunga NP, Ramogola WP, Viljoen AM. South African Salvia species: A review of biological activities and phytochemistry. J Ethnopharmacol 2008; 119(3): 664-672.  Back to cited text no. 14
    
15.
Cardile V, Russo A, Formisano C, Rigano D, Senatore F, Arnold NA, et al. Essential oils of Salvia bracteata and Salvia rubifolia from Lebanon: Chemical composition, antimicrobial activity and inhibitory effect on human melanoma cells. J Ethnopharmacol 2009; 126(2): 265-272.  Back to cited text no. 15
    
16.
Privitera G, Napoli E, Luca T, Ruberto G, Castorina S. In vitro anti-proliferative effect of Salvia officinalis essential oil and its three main components on human lung cancer cells. Am J Phytomedicine Clin Therapeuthics 2014; 2(10): 1159-1168.  Back to cited text no. 16
    
17.
Napoli EM, Ruberto G. Sicilian aromatic plants: From traditional heritage to a new agro-industrial exploitation. In: Kralis JF (ed). Spices: Types, uses and health benefits. New York, USA: NovaPublishers; 2012, p. 1-56.  Back to cited text no. 17
    
18.
Khedher MRB, Khedher SB, Chaieb I, Tounsi S, Hammami M. Chemical composition and biological activities of Salvia officinalis essential oil from Tunisia. EXCLI J 2017; 16: 160-173. Doi: 10.17179/excli2016-832.  Back to cited text no. 18
    
19.
Granata G, Stracquadanio S, Leonardi M, Napoli E, Consoli G, Cafiso V, et al. Essential oils encapsulated in polymer-based nanocapsules as potential candidates for application in food preservation. Food Chem 2018; 269: 286-292.  Back to cited text no. 19
    
20.
Privitera G, Luca T, Musso N, Vancheri C, Crimi N, Barresi V, et al. In vitro antiproliferative effect of trastuzumab (Herceptin(®)) combined with cetuximab (Erbitux(®)) in a model of human non-small cell lung cancer expressing EGFR and HER2. Clin Exp Med 2016; 16(2): 161-168.  Back to cited text no. 20
    
21.
ABICH S.r.l. Citotoxicity evaluation. [Online]. Available from: onetruthusa.com/wp-content/uploads/2016/05/Cytotoxicity-Abich- Report.pdf [Accessed on 5 February 2018].  Back to cited text no. 21
    
22.
Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev 2016; 17(S3): 43-46.  Back to cited text no. 22
    
23.
Wong MC, Goggins WB, Wang HH, Fung FD, Leung C, Wong SY, et al. Global incidence and mortality for prostate cancer: Analysis of temporal patterns and trends in 36 countries. Eur Urol 2016; 70(5): 862-874. Doi: 10.1016/j.eururo.2016.05.043.  Back to cited text no. 23
    
24.
Özkan A, Erdoǧan A. A comparative evaluation of antioxidant and anticancer activity of essential oil from origanum onites (lamiaceae) and its two major phenolic components. Turk J Biol 2011; 35(6): 735-742.  Back to cited text no. 24
    
25.
Biswas R, Mandal SK, Dutta S, Bhattacharyya SS, Boujedaini N, Khuda- Bukhsh AR. Thujone-rich fraction of thuja occidentalis demonstrates major anti-cancer potentials: evidences from in vitro studies on A375 cells. Evid Based Complement Alternat Med 2011; 2011: 568148. Doi: 10.1093/ecam/neq042.  Back to cited text no. 25
    
26.
Zhou Y, Liu JQ, Zhou ZH, Lv XT, Chen YQ, Sun LQ, et al. Enhancement of CD3AK cell proliferation and killing ability by α -thujone. Int Immunopharmacol 2016; 30: 57-61.  Back to cited text no. 26
    
27.
Siveen KS, Kuttan G. Thujone inhibits lung metastasis induced by B16F- 10 melanoma cells in C57BL/6 mice. Can J Physiol Pharmacol 2011; 89(10): 691-703.  Back to cited text no. 27
    
28.
Nikolić B, Vasilijević B, Mitić-Ćulafić D, Vuković-Gačić B, Knežević- Vukćević J. Comparative study of genotoxic, antigenotoxic and cytotoxic activities of monoterpenes camphor, eucalyptol and thujone in bacteria and mammalian cells. Chem Biol Interact Int 2015; 242: 263-271.  Back to cited text no. 28
    
29.
Gautam N, Mantha AK, Mittal S. Essential oils and their constituents as anticancer agents: A mechanistic view. BioMed Res Int 2014; 2014: 154106. Doi: 10.1155/2014/154106.  Back to cited text no. 29
    
30.
Waris G, Ahsan H. Reactive oxygen species: Role in the development of cancer and various chronic conditions. J Carcinog 2006; 5: 14.  Back to cited text no. 30
    
31.
Calabrese V, Giordano J, Signorile A, Laura Ontario M, Castorina S, De Pasquale C, et al. Major pathogenic mechanisms in vascular dementia: Roles of cellular stress response and hormesis in neuroprotection. J Neurosci Res 2016; 94(12): 1588-1603.  Back to cited text no. 31
    
32.
Sharifi-Rad J, Sureda A, Tenore GC, Daglia M, Sharifi-Rad M, Valussi M, et al. Biological activities of essential oils: From plant chemoecology to traditional healing systems. Molecules 2017; 22(1): E70. Doi: 10.3390/ molecules22010070.  Back to cited text no. 32
    
33.
Blowman K, Magalhães M, Lemos MFL, Cabral C, Pires IM. Anticancer properties of essential oils and other natural products. Evid Based Complement Alternat Med 2018; 2018: 3149362. Doi: 10.1155/2018/3149362.  Back to cited text no. 33
    
34.
Cha, JD, Kim HY, Kim YJ. Essential oil and 1,8-cineole from Artemisia lavandulaefolia induces apoptosis in KB cells via mitochondrial stress and caspase activation. Food Sci Biotechnol 2010; 19(1): 185-191.  Back to cited text no. 34
    
35.
Akrout A, Gonzalez LA, El Jani H, Madrid PC. Antioxidant and antitumor activities of Artemisia campestris and Thymelaea hirsuta from southern Tunisia. Food Chem Toxicol 2011; 49(2): 342-347.  Back to cited text no. 35
    
36.
Yu JQ, Lei JC, Zhang XQ, Yu HD, Tian DZ, Liao ZX. Anticancer, antioxidant and antimicrobial activities of the essential oil of Lycopus lucidus Turcz. var. hirtus Regel. Food Chem 2011; 126(4): 1593-1598.  Back to cited text no. 36
    
37.
Gomes MRF, Schuh RS, Jacques ALB, Augustin OA, Bordignon SAL, Dias DO, et al. Citotoxic activity evaluation of essential oils and nanoemulsions of Drimys angustifolia and D. brasiliensis on human glioblastoma (U-138 MG) and human bladder carcinoma (T24) cell lines in vitro. Rev Bras Farmacogn 2013; 23(2): 259-267.  Back to cited text no. 37
    
38.
Nanyonga SK, Lewu F, Opoku AR, Oyedeji. Chemical composition, antioxidant activity and cytotoxicity of the essential oils of the leaves and stem of Tarchonanthus camphoratus. Afr J Pharm Pharmaco 2013; 7(7): 360-367.  Back to cited text no. 38
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  2. Materials and...
  In this article
Abstract
1. Introduction
3. Results
4. Discussion
References
Article Figures

 Article Access Statistics
    Viewed1003    
    Printed52    
    Emailed1    
    PDF Downloaded225    
    Comments [Add]    

Recommend this journal